戻る Agenda
Session 5 Track 3 - New Realities: Managing Drug Shortages
Session Chair(s)
Sandra Alderdice
Regulatory Affairs Supervisor, Office of Regulatory Affairs, BGTD
Health Canada, Canada
The management of a drug shortage involves collaborative efforts by multiple stakeholders and authorities to minimize patient impact. This session will explore how drug shortages across Canada are managed. It will provide an overview of significant global regulatory and legislative developments shaping supply chain management. It will consider how drug shortages can be avoided by monitoring real compliance data and increasing organizational communication. Finally, this session will look at public health issues involving shortages and illustrate a case example highlighting how the Public Health Agency of Canada, Health Canada and manufacturers around the world worked together to find alternative products.
Speaker(s)
Managing Drug Shortages by Monitoring Real Compliance Data: Global Developments Affecting Drug Supply Chains
Mujadala Abdul-Majid, JD, MS, RAC
3E Company, United States
Senior Regulatory Analyst
Addressing Drug Shortages in Canada
Etienne Ouimette
Health Canada, Canada
Director, Strategic Horizontal Policy Division
Drug Shortages and Public Health : A Case Study of BCG Vaccine
Cathy A. Parker
Health Canada, Canada
Director General, Biologics & Genetic Therapies Directorate HPFB